Sodium oxybate post-marketing surveillance
- PMID: 21897785
- PMCID: PMC3161780
- DOI: 10.5664/JCSM.1216
Sodium oxybate post-marketing surveillance
References
-
- United States Securities and Exchange Commission. Jazz Pharmaceuticals, Inc.; [March 31, 2011]. Form 10-Q. Available: http://www.faqs.org/sec-filings/110509/JAZZ-PHARMACEUTICALS-INC_10-Q/
-
- Figueiras A, Tato F, Fontaiñas J, Gestal-Otero JJ. Influence of physicians' attitudes on reporting adverse drug events: a case-control study. Med Care. 1999;37:809–14. - PubMed
-
- Bäckström M, Mjörndal T, Dahlqvist R. Under-reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf. 2004;13:483–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
